SEC Form 4 · accession 0001809519-26-000125
GoodRx Holdings, Inc. · GDRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald E Bruehlman
Director
Period of report
Jun 16, 2026
Accepted (ET)
Jun 17, 2026 · 8:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001809519
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jun 16, 2026 | A | 73,434 | $0.00 | A | 207,352 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) the one-year anniversary of June 16, 2026 and (ii) the date of the 2027 Annual Meeting of Stockholders, subject to Reporting Person's continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2031; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).